Hermanns, Thomas

Systemic inflammatory markers have independent prognostic value in patients with metastatic testicular germ cell tumours undergoing first-line chemotherapy

Fankhauser, C. D., Sander, S., Roth, L., Gross, O., Eberli, D., Sulser, T., Seifert, B., Beyer, J., & Hermanns, T. (2018) · British Journal of Cancer

Inflammatory Biomarkers in Disease PrognosisTesticular diseases and treatments

Cited by 80

The structural basis for deubiquitination by the fingerless USP-type effector TssM

Hermanns, T., Uthoff, M., Baumann, U., & Hofmann, K. (2024) · Life Science Alliance

Ubiquitin and proteasome pathwaysEnzyme Structure and Function

Cited by 7

The structural basis for deubiquitination by the fingerless USP-type effector TssM

Hermanns, T., Uthoff, M., Baumann, U., & Hofmann, K. (2023) · Life Science Alliance

Ubiquitin and proteasome pathwaysEnzyme Structure and Function

Cited by 7

Enzalutamide Plus Metformin Versus Enzalutamide Alone in Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 2 Trial (SAKK 08/14).

Gillessen, S., Gobat, K., Cathomas, R., Fischer, N., Pereira Mestre, R., Hermanns, T., Rothschild, S. I., Mach, N., Mingrone, W., Ciriolo, M., et al. (2026) · European Urology Oncology

Prostate Cancer Treatment and ResearchMetabolism, Diabetes, and Cancer

Cited by 4